Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solvac S.A. Proxy Solicitation & Information Statement 2026

Mar 6, 2026

4004_rns_2026-03-06_f80b88e9-6f46-4c66-8fa4-ad435dd4ed82.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

Solvac

Press release

Regulated information

Brussels, March 6, 2026, 5.45 pm CET

Solvac proposes to its shareholders the option of choosing dematerialized shares in addition to registered shares, the removal of the approval procedure for legal entities, and the granting of double voting rights on each registered share held for at least two years.

At its next Extraordinary General Meeting on 12 May 2026, Solvac will propose to shareholders an amendment to its Articles of Association, effective 1 October 2026, consisting of:

  • authorizing each shareholder to hold all or part of their shares in dematerialized form,
  • removing the requirement for prior approval of legal entities,
  • granting a second voting right to each registered share held by the same shareholder for an uninterrupted period of two years.

These initiatives are intended to:

  • allow each shareholder to choose the form of share they wish to hold, while promoting shareholder stability,
  • grant a second loyalty voting right to shareholders who, through Solvac, provide long-term support for the strategic and industrial vision of its holdings, and
  • attract new shareholders who see Solvac as a company committed to creating sustainable value.

Dematerialized shares and free holding

The dematerialized form will coexist with the registered form of Solvac shares. In dematerialized form, Solvac shares may be freely traded on Euronext Brussels between natural persons, legal entities and/or similar entities, without prior approval from the Board of Directors. This measure is intended to facilitate the trading of securities and enable a wider range of investors to hold Solvac shares.

Double voting rights

The two-year period for obtaining a second voting right will begin to run from the date of registration of the registered shares in Solvac's register, even if this took place before the adoption of double voting rights by the Extraordinary General Meeting. In case of a conversion of their shares by a shareholder into dematerialized ones, the double voting right will be lost.


2

Proposal and notice of the Extraordinary General Meeting of 12 May 2026

The notice and agenda for the Extraordinary General Meeting of 12 May 2026 will be communicated and published on 10 April 2026 in accordance with the law. An explanatory note and FAQ will also be available.

Jean-Marie Solvay, Chairman of the Board of Directors of Solvac, comments:

"Solvac is driven by the conviction that chemistry is a driver of innovation and a source of answers and solutions that will enable society to meet the challenges of energy and ecological transition. This project, which we have been working on for several months, will make Solvac more flexible and agile, giving our shareholders the choice to opt for dematerialized shares while recognizing the loyalty of our registered shareholders."

Solvac is a public limited company under Belgian law founded in 1983 and listed on the Euronext Brussels stock exchange under the ISIN code BE0003545531 (SOLV). Its assets consist exclusively of a stake of more than 30% in the capital of Solvay SA and in the capital of Syensqo SA. Its titles are exclusively nominative. They may be held freely by individuals or, with the approval of the Board of Directors, by legal entities or similar entities under the conditions set out in their approval policy. As of December 31, 2025, its market capitalization amounted to € 1.75 billion.

For more information, please contact:

SOLVAC S.A.
Champs Elysées street, 43
B - 1050 Brussels
Tel. : 32/2/639 66 30
Email : [email protected]

Ce communiqué de presse est également disponible en français - Dit persbericht is ook in het Nederlands beschikbaar